Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis

NCT02389075 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02389075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02389075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Active, not recruiting
Start date
March 31, 2015
Completion date
October 31, 2026
Enrollment
129 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis (as), inflammatory bowel diseases (ibd)